Capricor Therapeutics INC

Capricor Therapeutics signed a lease for a new 171,000-square-foot headquarters in San Diego, including expanded manufacturing cleanrooms, R&D labs, and offices. The initial monthly rent is about $958,000 with 3% annual increases, but the company receives an 18-month full rent abatement and a six-month partial abatement. The lease term begins when an FDA approval condition for Deramiocel is met or by Dec 31, 2026, whichever comes first, and rent starts 12 months later. If FDA approval does not occur by year-end, either party can terminate the lease.